StoneRidge PMG Advisors, LLC’s Niagen Bioscience NAGE Stock Holding History
Bought
Maintained
Sold
Other funds holding NAGE
StoneRidge PMG Advisors, LLC's NAGE Position: Q3 2026 in Review
StoneRidge PMG Advisors, LLC sold out of Niagen Bioscience (NAGE) in Q3 2026, closing a stake of 14,477 shares — an estimated $49K sold.
StoneRidge PMG Advisors, LLC first reported a position in NAGE in Q4 2025 and held it in 3 quarters. The position peaked at $322K in Q4 2025. 124 funds tracked by Wall St. Rank hold NAGE as of Q3 2026.
- StoneRidge PMG Advisors, LLC reported no remaining Niagen Bioscience position as of Q3 2026 after selling out during the quarter.
- StoneRidge PMG Advisors, LLC sold 14,477 Niagen Bioscience shares in Q3 2026, an estimated $49K.
- StoneRidge PMG Advisors, LLC first reported a position in Niagen Bioscience in Q4 2025 and held it in 3 quarters.
- StoneRidge PMG Advisors, LLC's Niagen Bioscience position peaked at $322K in Q4 2025.
- 124 funds tracked by Wall St. Rank held Niagen Bioscience as of Q3 2026.
Based on StoneRidge PMG Advisors, LLC's 13F filing for Q3 2026, filed 4 Nov 2026.